Obstetrics, Gynecology, & Neonatal

6 mins

Laborie Acquires the JADA® System for Rapid Postpartum Hemorrhage Control, Expanding Obstetrics Portfolio

Laborie Medical Technologies Corp (“Laborie”) today announced the closing of…

Written By Laborie

Obstetrics, Gynecology, & Neonatal

5 mins

Laborie Announces Agreement to Acquire the JADA® System from Organon

Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies…

Written By Laborie

General News

4 mins

Laborie Announces First Procedures in ENDURE 1 Study with the Optilume® Ureteric Drug-Coated Balloon

Landmark procedures launch the ENDURE 1 clinical study evaluating Optilume’s…

Written By Laborie

General News

3 mins

Laborie Appoints Chris Smith as Chief Executive Officer

Laborie Medical Technologies Corp., a global leader in medical technology,…

Written By Laborie

Urology & Urogynecology

4 mins

Laborie’s Optilume® Drug-Coated Balloon for Stricture Secures Coverage from BCBS of Michigan

Effective July 1, 2025, Blue Cross Blue Shield of Michigan…

Written By Laborie

Urology & Urogynecology

4 mins

Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures

Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic…

Written By Laborie

Urology & Urogynecology

3 mins

Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology

Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and…

Written By Laborie

General News |

Urology & Urogynecology

3 mins

Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association

Laborie Medical Technologies Corp (Laborie), announced today that the American…

Written By Laborie